ClinVar Miner

Submissions for variant NM_024312.5(GNPTAB):c.204-15G>T

gnomAD frequency: 0.01423  dbSNP: rs10860787
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 9
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Illumina Laboratory Services, Illumina RCV000328472 SCV000375449 benign Mucolipidosis type II 2018-01-13 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.
Illumina Laboratory Services, Illumina RCV000380692 SCV000375450 benign Pseudo-Hurler polydystrophy 2018-01-13 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000587904 SCV000699477 benign not provided 2016-10-10 criteria provided, single submitter clinical testing Variant summary: The GNPTAB c.204-15G>T variant involves the alteration of a non-conserved intronic nucleotide. Mutation taster predicts a benign outcome for this variant along with 5/5 splice prediction tools predict no significant impact on splicing. This variant was found in 5864/121394 control chromosomes (675 homozygotes), predominantly observed in the East Asian subpopulation at a frequency of 0.3188339 (2756/8644). This frequency greatly exceeds the estimated maximal expected allele frequency of a pathogenic GNPTAB variant (0.0022361), indicating this is a benign polymorphism found primarily in the populations of East Asian origin. The variant of interest has not, to our knowledge, been reported in affected individuals via publications nor evaluated for functional impact by in vivo/vitro studies. One reputable clinical lab has classified the variant as benign. Taken together, this variant is classified as benign.
GeneDx RCV000587904 SCV000975317 benign not provided 2018-06-19 criteria provided, single submitter clinical testing This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.
Labcorp Genetics (formerly Invitae), Labcorp RCV001518439 SCV001727130 benign Mucolipidosis type II; Pseudo-Hurler polydystrophy 2025-01-28 criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV000328472 SCV001749159 benign Mucolipidosis type II 2021-07-01 criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV000380692 SCV001749160 benign Pseudo-Hurler polydystrophy 2021-07-01 criteria provided, single submitter clinical testing
Breakthrough Genomics, Breakthrough Genomics RCV000587904 SCV005235019 benign not provided criteria provided, single submitter not provided
Mayo Clinic Laboratories, Mayo Clinic RCV000587904 SCV000800959 benign not provided 2017-12-06 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.